Well-differentiated thyroid carcinomas: p53 mutation status and microvessel density

Head and Neck

Volumn 20, Issue 2, 1998, Pages 152-158

  Goldenberg, John D ^a   Portugal, Louis G ^a   Wenig, Barry L ^a   Ferrer, Karen ^b   Wu, James C ^b   Sabnani, Jaishiri ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Carcinoma; CD34; Microvessel density; p53; Thyroid

Indexed keywords

BIOLOGICAL MARKER; CD34 ANTIGEN; PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; THYROID CARCINOMA; THYROIDECTOMY; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGE FACTORS; ANTIGENS, CD34; CAPILLARIES; CARCINOMA; CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; REGISTRIES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL RATE; THYROID NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0031930287     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(199803)20:2<152::AID-HED9>3.0.CO;2-1     Document Type: Article

References (31)

1. Segal K, Fridental R, Lubin E, Shvero J, Sulkes J, Feinmesser R. Papillary carcinoma of the thyroid. Otolaryngol Head Neck Surg 1995;113:356-363.
2. Goepfert H, Callender D. Differentiated thyroid cancer -papillary and follicular carcinomas. Am J Otolaryngol 1994;15:167-179.
3. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088-1095.
4. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 Mutations in human cancers. Science 1991;253:49-53.
5. Pavelic ZP, Portugal LG, Gootee MJ. Retrieval of p53 protein in paraffin-embedded head and neck tumor tissues. Arch Otolaryngol Head Neck Surg 1993;119:1206-1209.
6. Dobashi Y, Sugimura H, Sakamoto A, et al. Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas. Diagnost Mol Pathol 1994; 3:9-14.
7. Midgley CA, Fisher CJ, Bartek J, Vojtesek B, Lane D, Barnes DM. Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci 1992;101:183-189.
8. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988; 104:947-953.
9. Shah JP, Loree TR, Dharker D, Strong EW, Begg C. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992;164:658-661.
10. Rosen IB, Bowden J, Luk SC, Simpson JA. Aggressive thyroid cancer in low-risk age population. Surgery 1987; 102:1075-1080.
11. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991;351:453-456.
12. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc 70-p53 complex with an altered half-life. Mol Cell Biol 1988;8: 531-539.
13. Zou M, Shi Y, Farid NR. p53 Mutations in all stages of thyroid carcinomas. J Clin Endocrinol Metab 1993;77: 1054-1058.
14. Wynford-Thomas D. p53 In tumour pathology: Can we trust immunohistochemistry? J Pathol 1992;166: 329-330.
15. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang S, Koeffler HP. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 1993;91:179-184.
16. Ito T, Seyama T, Mizuno T, et al. Genetic alterations in thyroid tumor progression: association with p53 gene mutations. Jpn J Cancer Res 1993;84:526-531.
17. Matias-Guiu X, Cuatrecasas M, Musulen E, Prat J. p53 Expression in anaplastic carcinomas arising from papillary carcinomas. J Clin Pathol 1994;47:337-339.
18. Donghi R, Longoni A, Pilotti S, Michieli P, Della Porta G, Pierotti M. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest 1993;91:1753-1760.
19. Gimbrone MA, Leapman S, Cotran RS, et al. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 1972;136:261-276.
20. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate thickness (0.76-4.0 mm thick) skin melanoma. Am J Pathol 1988;133:419-423.
21. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis,-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
22. Bosari S, Lee AKC, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-761.
23. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-146.
24. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-409.
25. Gasparini G, Weidner N, Maluta S, et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 1993;55:739-744.
26. Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-1124.
27. Fina L, Molgaard HV, Robertson D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood 1990; 75:2417-2426.
28. Traweek ST, Kandalaft PL, Mehta P, Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasi. Am J Clin Pathol 1991;96:25-31.
29. Dray TG, Hardin NJ, Sofferman RA. Angiogenesis as a prognostic marker in early head and neck cancer. Ann Otol Rhinol Laryngol 1995;104:724-729.
30. Zatterstrom UK, Brun E, Willen R, Kjellen E, Wennerberg J. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck 1995;17: 312-318.
31. Leedy DA, Trune DR, Kronz JD, Weidner N, Cohen JI. Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous cell carcinoma of the tongue. Otolarygol Head Neck Surg 1994;111:417-422.